CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples